Home   >  

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials

Wnt/Stem Cell

Chemical Structure Cat. No. Product Name CAS No.
PKA Inhibitor (5-24) Chemical Structure
BCP35218 PKA Inhibitor (5-24) 99534-03-9
PKA Inhibitor (5-24) is a potent, competitive, and synthetic peptide inhibitor of PKA (cAMP-dependent protein kinase), with a Ki of 2.3 nM. PKI(5-24) corresponds to residues 5-24 in the naturally occurring heat-stable protein kinase inhibitor.
YAP/TAZ inhibitor-1 Chemical Structure
BCP35165 YAP/TAZ inhibitor-1 2093565-23-0
YAP/TAZ inhibitor-1 is a YAP/TAZ inhibitor.
TG-89 Chemical Structure
BCP35054 TG-89 936091-56-4
TG-89 is an inhibitor of JAK2, FLT3, RET and JAK3.
CK1-IN-1 Chemical Structure
BCP35045 CK1-IN-1 1784751-20-7
CK1-IN-1 is a casein kinase 1 (CK1) inhibitor extracted from patent WO2015119579A1, compound 1c, has IC50s of 15 nM, 16 nM, 73 nM for CK1δ, and CK1ε, p38σ MAPK, respectively.
PRI-724 Chemical Structure
BCP32677 PRI-724 1422253-38-0
PRI-724 is a selective inhibitor of the CBP/β-catenin interaction.
Delgocitinib Chemical Structure
BCP34832 Delgocitinib 1263774-59-9
Delgocitinib is a specific JAK inhibitor with IC50s of 2.8, 2.6, 13 and 58 nM for JAK1, JAK2, JAK3 and Tyk2, respectively.
TC-S 7001 Chemical Structure
BCP34134 TC-S 7001 867017-68-3
TC-S 7001 is an orally active and ATP-competitive ROCK inhibitor with IC50s of 0.6 and 1.1 nM for human ROCK-1 and ROCK-2, respectively.
KY1220 Chemical Structure
BCP34008 KY1220 292168-79-7
KY1220 is a small molecule that simultaneously degrades β-catenin and Ras by inhibition of the Wnt/β-catenin pathway.
PF-06826647 Chemical Structure
BCP33615 PF-06826647 2127109-84-4
PF-06826647(Tyk2-IN-8) is a selective TYK2 inhibitor, which binds to TYK2 catalytically active JH1 domain with an IC50 of 17 nM, used in the treatment of psoriasis.
Alsterpaullone Chemical Structure
BCP33241 Alsterpaullone 237430-03-4
Alsterpaullone, also known as 9-Nitropaullone and NSC 705701, is a derivative of kenpaullone and an ATP-competitive inhibitor of several cyclin-dependent kinases (CDKs) as well as glycogen synthase kinase 3β (GSK3β).
123下一页末页共 308 条记录 1 / 31 页